Trials / Completed
CompletedNCT03526666
Ascorbic Acid Levels in MDS, AML, and CMML Patients
Collection of Peripheral Blood From Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia for Measuring Baseline Ascorbic Acid Levels and Future Epigenetic Cancer Research
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Van Andel Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a non-interventional, specimen collection translational study to evaluate vitamin C levels in the peripheral blood of Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML) patients.
Detailed description
It has previously been established that hematological cancer patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) often exhibit severe vitamin C deficiency from a cohort of patients in Copenhagen. In this study, the investigators aim to determine if those results are conserved in another population/geographical location.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Peripheral blood collection | Peripheral blood collection for the measurement of ascorbic acid levels and banking of plasma and buffy coat for future resrearch. |
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2018-10-31
- Completion
- 2018-10-31
- First posted
- 2018-05-16
- Last updated
- 2019-10-03
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03526666. Inclusion in this directory is not an endorsement.